Effect of Supplementation in combination with diet therapy in treatment of polycystic ovary syndrome

Not Applicable

Conditions: Condition 1: polycystic ovary syndrome. Condition 2: .
Polycystic ovarian syndrome

Registration Number: IRCT20120913010826N30

Lead Sponsor: Yazd University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 40

Inclusion Criteria

_aged 18-40 years _BMI between 25 to 40 _Serum vitamin D levels less than 20 ng /ml _not using weight loss diet and vitamin D supplement Over the last 3 months _not using hormone therapy _not using certain drugs including Weight loss drugs and multivitamin supplements mineral _not smoking
_Patients with PCOS according to Rotterdam criteria
_not doing heavy and professional exercise

Exclusion Criteria

individuals with diabetes, Cardiovascular disease, Liver, kidney, thyroid and para- thyroid, Cushing's syndrome, osteomalaci _Non-compliance with diet and supplementation _changes in physical activity

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
25OHD (25-hydroxy vitamin D). Timepoint: Befor and after 12 weeks treatment. Method of measurement: Using ELISA.

Secondary Outcome Measures

Name	Time	Method
eptin serum level. Timepoint: Befor and after 12 weeks treatment. Method of measurement: Using ELISA.;Weight. Timepoint: Befor and after 12 weeks treatment. Method of measurement: OMRON scale with an accuracy of 0.1kg.;Body mass index. Timepoint: Befor and after 12 weeks treatment. Method of measurement: weight/ height*height.;Weist circumference. Timepoint: Befor and after 12 weeks treatment. Method of measurement: By meter in cm.;Hip circumference. Timepoint: Befor and after 12 weeks treatment. Method of measurement: By meter in cm.;Percent of body fat, percent of free fat mass. Timepoint: Befor and after 12 weeks treatment. Method of measurement: Body composition device.